Navigation Links
Securing the future of Europe's biological data resources
Date:5/28/2008

In a contract signed today, the European Commission has awarded 4.5 million to a pan-European consortium to decide upon the best way to unite Europes biological data resources into a sustainable, integrative bioinformatics network for the life sciences. The European Life-science Infrastructure for Biological Information (ELIXIR) project is led by the European Molecular Biology Laboratorys European Bioinformatics Institute (EMBL-EBI) and involves 32 partners from 13 countries. The consortium ultimately aims to establish a sustainably funded infrastructure for biological information in Europe, to support innovation in life science research, knowledge generation and its translation to medicine, the environment, the bio-industries and society.

Since the 1980s, the storage mechanism for biological information has gone from being an individuals notebook and published academic papers to open source databases of integrated information exchanged worldwide on a daily basis. This information and the databases that make it available to scientists around the world are an indispensable resource for modern biology. Yet commonly these resources are dependent on insecure or short term funding, meaning that the valuable data they contain and provide access to, are jeopardised when funding ends.

ELIXIR aims to protect the existing and future data held in biological data resources. The project will work to provide a European infrastructure for optimal information storage, access and integration supported by a secure funding mechanism. "Under the Framework Programme for Research, the European Commission provides support to the preparatory phase for the construction of new research infrastructures, commented Mr Robert-Jan Smits, Director of Directorate B (European Research Area: Research Programmes and Capacity) at DG Research of the European Commission. This will help catalyse the efforts and resources needed to build and ensure the sustainability of large-scale, word-class infrastructures needed by Europe's research communities." In this way, the longevity of Europes central molecular data resources will be guaranteed.

The development of such a network is a strategic step in maintaining the global position of Europe as a leader in scientific research. The biological sciences are delivering benefits that contribute to advances in our society, says EMBL-EBI director and ELIXIR coordinator Janet Thornton. Developing a securely funded, integrative infrastructure will give Europe one voice in the global community, meaning that we can make connections and realise those benefits more quickly by working together, she concludes.


'/>"/>

Contact: Louisa Wright
louisa@ebi.ac.uk
44-122-349-4665
European Molecular Biology Laboratory
Source:Eurekalert

Related biology news :

1. Great Plains historical stability vulnerable to future changes
2. Gene may hold key to future cancer hope
3. DOE publishes update of plan: Facilities for the Future of Science: A 20-Year Outlook
4. NASA technology helps predict and prevent future pandemic outbreaks
5. Sunbathing tree frogs future under a cloud
6. Methane from microbes: a fuel for the future
7. Setting a course for the future of tissue engineering
8. Air quality forecasts see future in space
9. Oceans Past: A Guide to Oceans Future
10. Building the future -- 21st century nano tools to repair the nervous system
11. Climate change in the Baltic Sea basin -- past, present and future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: